Gene Review:
POU5F2 - POU domain class 5, transcription factor 2
Homo sapiens
Synonyms:
FLJ25680, POU domain, class 5, transcription factor 2, SPRM-1, SPRM1, Sperm 1 POU domain transcription factor
- Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis. Chwalisz, K., Perez, M.C., Demanno, D., Winkel, C., Schubert, G., Elger, W. Endocr. Rev. (2005)
- A novel selective progesterone receptor modulator asoprisnil (J867) inhibits proliferation and induces apoptosis in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells. Chen, W., Ohara, N., Wang, J., Xu, Q., Liu, J., Morikawa, A., Sasaki, H., Yoshida, S., Demanno, D.A., Chwalisz, K., Maruo, T. J. Clin. Endocrinol. Metab. (2006)
- Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family. Mastroberardino, L., Spindler, B., Pfeiffer, R., Skelly, P.J., Loffing, J., Shoemaker, C.B., Verrey, F. Nature (1998)
- The effects of 1-month administration of asoprisnil (J867), a selective progesterone receptor modulator, in healthy premenopausal women. Chwalisz, K., Elger, W., Stickler, T., Mattia-Goldberg, C., Larsen, L. Hum. Reprod. (2005)
- Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications. Chabbert-Buffet, N., Meduri, G., Bouchard, P., Spitz, I.M. Hum. Reprod. Update (2005)
- Selective estrogen receptor modulator and selective progesterone receptor modulator: therapeutic efficacy in the treatment of uterine leiomyoma. Ohara, N. Clinical and experimental obstetrics & gynecology. (2005)
- Synthesis and biological activity of 5-methylidene 1,2-dihydrochromeno[3,4-f]quinoline derivatives as progesterone receptor modulators. Zhi, L., Tegley, C.M., Pio, B., Edwards, J.P., Jones, T.K., Marschke, K.B., Mais, D.E., Risek, B., Schrader, W.T. Bioorg. Med. Chem. Lett. (2003)